Clinical Characteristics of Anti-mGluR5 Encephalitis: A Systematic Review
Overview
This systematic review identifies 60 patients with anti-mGluR5 encephalitis, highlighting a diverse clinical presentation and the relationship between MRI findings and symptoms. Key findings include a lower tumor association in Chinese patients and a higher prevalence of cognitive deficits in MRI-positive individuals.
Background
Anti-mGluR5 encephalitis is a rare autoimmune disorder characterized by antibodies targeting the metabotropic glutamate receptor 5, leading to various neurological symptoms. Understanding its clinical features and MRI correlations is crucial for accurate diagnosis and management, especially given its potential association with tumors and the variability in presentation among different populations.
Data Highlights
Characteristic
Percentage
Patients with cognitive deficits
95.2% (MRI-positive)
Patients with tumors
25.0%
MRI abnormalities
52.5%
CSF positivity for anti-mGluR5 antibodies
54.8%
Serum positivity for anti-mGluR5 antibodies
96.8%
Key Findings
Common manifestations include cognitive deficits, behavioral disturbances, and seizures.
25% of patients had tumors, with a significant difference between Western (60%) and Chinese (4%) patients.
52.5% of patients exhibited brain MRI abnormalities.
CSF positivity for anti-mGluR5 antibodies was lower than serum positivity (54.8% vs. 96.8%).
Cognitive deficits were more frequent in MRI-positive patients (95.2% vs. 68.4%).
Clinical Implications
Highlight the importance of considering normal MRI results in the diagnostic process.
Conclusion
The findings underscore the clinical heterogeneity of anti-mGluR5 encephalitis and suggest that MRI findings may not always correlate with clinical severity, warranting further research to confirm these patterns.
